联合介入治疗主动脉夹层并冠心病的安全性及临床疗效

Joint intervention in the treatment of thoracic aortic dissection and coronary heart disease safety and clinical efficacy

目的评价覆膜支架联合PCI介入治疗Stanford B型主动脉夹层并冠心病的安全性及临床疗效。方法2002年1月至2008年6月完成的20例先后行覆膜支架联合PCI治疗Stanford B型主动脉夹层并冠心病患者，观察住院及随防期间覆膜支架内漏、冠状动脉支架血栓形成、心力衰竭、死亡、截瘫、肾功能情况。结果手术成功率100％，术后即刻造影16例近端破口完全封堵，4例少量残余内漏，无截瘫、肾功能不全、心力衰竭、心绞痛、亚急性血栓形成、死亡，随防6个月至2年，复查腹主动脉增强CT示夹层支架封闭良好。结论覆膜支架联合PCI介入治疗Stanford B型主动脉夹层并冠心病安全、有效。

Objective To evaluate the clinical efficacy and safety of interventional treatment in patients with Stanford B thoracic aortic dissection and coronary heart disease by endovascular graf exclusion（EVGE） and pereutaneous coronary intervention（PCI） respectively. Methods From January 2002 to June 2008,20 patients with Stanford B thoracic aortic dissection and coronary heart disease received successive EVGE and PCI in our hospital ,Observed during hospitalization and follow-EVGE endoleak, Coronary stent thrombosis, heart failure, death, paraplegia, renal function. Results 100 percent success rate of surge-ry, immediately after the 16 cases of proximal contrast break completely sealing, four eases with a small amount of residual leakage, no paraplegia, renal insufficiency, heart failure, angina, subacute thrombosis, death,with the anti-6 months to 2 years, a review of abdominal aortic dissection stent enhanced CT showed good closure. Conclusion Joint intervention in the treatment of thoracic aortic dissection and coronary heart disease is safe and effective